Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Adamas Pharma (ADMS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Adamas Pharmaceuticals Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Adamas Pharmaceuticals Inc historical data, for real-time data please try another search
8.220 +0.000    +0.00%
23/11 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 8.230 / 8.300
  • Day's Range: 8.180 - 8.250
Adamas Pharmaceuticals Inc 8.220 +0.000 +0.00%

ADMS Financial Summary

 
A brief financial summary of Adamas Pharma as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

For the nine months ended 30 September 2021, AdamasPharmaceuticals Inc revenues increased 26% to $67.2M. Netloss increased 14% to $44.4M. Revenues reflect Productsales increase of 23% to $63.1M, Royalty revenue increaseof 99% to $4.1M. Higher net loss reflects Other General andAdministrative. increase of 16% to $80.3M (expense),Stock-based Compensation in General increase of 16% to$5.2M (expense).

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ADMS Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Total Revenue 25.9 21.97 19.31 21.01
Gross Profit 25.32 21.45 18.93 20.41
Operating Income -5.64 -9.15 -9.53 -14.98
Net Income -19.52 -12.34 -12.57 -18.27

ADMS Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Total Assets 143.98 150.64 169.25 120.03
Total Liabilities 165.58 154.68 163.31 170
Total Equity -21.61 -4.03 5.94 -49.98

ADMS Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -153.06%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Period Length: 9 Months 6 Months 3 Months 12 Months
Cash From Operating Activities -36.49 -30.24 -21.06 -50.71
Cash From Investing Activities -22.07 -19.06 7.79 54.94
Cash From Financing Activities 65.52 66.44 66.44 1.65
Net Change in Cash 6.96 17.14 53.17 5.89
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ADMS Comments

Write your thoughts about Adamas Pharma
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
PlanetApe Ape
PlanetApe Ape Oct 11, 2021 9:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Juat in: Supernus Pharma To Acquire Adamas Pharma For Total Consideration Up To $9.10/shr
SS SS
SS SS Jun 05, 2020 12:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Adamas ? is it worths to entry ?
Raffael Cavaliere
Raffael Cavaliere Sep 19, 2018 12:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pressure to discuss the sale of the company seems to be growing up. https://chn.ge/2OEI2kD
Joel Hanson
Joel Hanson Nov 17, 2016 11:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
All 8 analyst covering ADMS recommend "buy." The average target price consensus for the next 12 months is $34 which is 110% ROI at its current price of $16.16.
Joe Mingoia
Joe Mingoia Nov 17, 2016 11:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
revenue is going to increase exponentially once this parkinsons drug gets out in circulation in January 18 .. that will be good for top and bottom line numbers come earning seasons.$$$$$. and mist of all definitely great for patients suffering.
Krypto Nite
Krypto Nite Nov 17, 2016 11:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Huh, so price targets me nothing. The more you know (it's not getting anywhere near $30 in the next 3 months)
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email